Latest News and Press Releases

The consolidated sales of the company for December 2010 amounted to 18.8 million LTL (5.4 million EUR) – 35% increase comparing to December 2009. Unaudited sales of the company for period January –...

Strong organic growth for Fagron and Corilus Waregem (Belgium) / Rotterdam (Netherlands)[1], 10 January 2011 - The consolidated turnover increased 9.3% to € 124.5 million in the fourth quarter of...

Start of phase II clinical study in patients for Sandoz biosimilar rituximab (Roche's Rituxan® / Mabthera®)[1]Sandoz already has robust, high-yield in-house production processMilestone reinforces...

The EGM in ChronTech Pharma AB The EGM in ChronTech Pharma AB on 7 January, 2011 resolved to authorize the Board to resolve new issue of shares,  warrants and/or convertible debentures and with or...

 · Den 31 december 2010 uppgick East Capital Explorers substansvärde per aktie till 12,34 EUR (motsvarande 111 SEK[1]). Det totala substansvärdet uppgick till 430 MEUR (motsvarande 3,9 mdr SEK)  ·...

 · On 31 December 2010 the net asset value per share in East Capital Explorer amounted to EUR 12.34 (corresponding to SEK 111[1]). The total net asset value amounted to EUR 430m (corresponding to SEK...

East Capital Explorer AB har gjort en direktinvestering om 6,8 MEUR i Wimm-Bill- Dann Foods OJSC, ett ledande mejeri- och juiceföretag i Ryssland, listat på börserna i Moskva och New York. "Vi ser...

East Capital Explorer AB has made a direct investment of EUR 6.8m in Wimm-Bill- Dann Foods OJSC, a leading dairy and juice company in Russia listed in Moscow and New York. Gert Tiivas, CEO East...

ChronTech Pharma AB:s extra bolagsstämma Den extra bolagsstämman i ChronTech Pharma AB den 7 januari 2011 bemyndigade styrelsen att besluta om nyemission av aktier, teckningsoptioner och/eller...

Stock Exchange release no. 1/2011 Published via NASDAQ OMX 10 January 2011   The financial calendar for Nordic Tankers A/S in 2011:   31 March...